These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7591242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E.
    Cancer Res; 1987 Jan 15; 47(2):388-93. PubMed ID: 3539321
    [Abstract] [Full Text] [Related]

  • 3. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
    Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N.
    Cancer Res; 1991 Jun 15; 51(12):3237-42. PubMed ID: 1645616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K.
    Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian-cancer cell lines.
    Nehmé A, Albin N, Caliaro MJ, Guichard S, Jozan S, Julia AM, Bugat R, Canal P.
    Int J Cancer; 1995 May 29; 61(5):643-8. PubMed ID: 7768637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 11. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ, Kelland LR, Harrap KR.
    Br J Cancer; 1993 Aug 15; 68(2):240-50. PubMed ID: 8347478
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
    Sark MW, Timmer-Bosscha H, Meijer C, Uges DR, Sluiter WJ, Peters WH, Mulder NH, de Vries EG.
    Br J Cancer; 1995 Apr 15; 71(4):684-90. PubMed ID: 7710929
    [Abstract] [Full Text] [Related]

  • 14. Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
    Küpeli S, Beksac M, Küpeli B, Baltaci S, Süzer O.
    Int Urol Nephrol; 1997 Apr 15; 29(4):421-6. PubMed ID: 9405998
    [Abstract] [Full Text] [Related]

  • 15. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH.
    Oncol Rep; 2009 Jul 15; 22(1):65-71. PubMed ID: 19513506
    [Abstract] [Full Text] [Related]

  • 16. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA.
    Cancer Res; 1994 Mar 15; 54(6):1497-502. PubMed ID: 8137254
    [Abstract] [Full Text] [Related]

  • 17. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
    Moers C, Warskulat U, Müschen M, Even J, Niederacher D, Josien R, Koldovsky U, Beckmann MW, Häussinger D.
    Int J Cancer; 1999 Feb 09; 80(4):564-72. PubMed ID: 9935158
    [Abstract] [Full Text] [Related]

  • 18. Determinants of drug response in a cisplatin-resistant human lung cancer cell line.
    Fujiwara Y, Sugimoto Y, Kasahara K, Bungo M, Yamakido M, Tew KD, Saijo N.
    Jpn J Cancer Res; 1990 May 09; 81(5):527-35. PubMed ID: 2116401
    [Abstract] [Full Text] [Related]

  • 19. [A study on the relationship between sensitivity to CDDP and inducibility of metallothionein and glutathione of genitourinary tumors].
    Yamagata K, Kondo Y.
    Nihon Hinyokika Gakkai Zasshi; 1995 Oct 09; 86(10):1575-82. PubMed ID: 7474609
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma downregulates Hsp27 expression and suppresses the negative regulation of cell death in oral squamous cell carcinoma lines.
    Yonekura N, Yokota S, Yonekura K, Dehari H, Arata S, Kohama G, Fujii N.
    Cell Death Differ; 2003 Mar 09; 10(3):313-22. PubMed ID: 12700631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.